NEW YORK, May 25 (GenomeWeb News) - Invitrogen, with two acquisitions already under its belt this year, has done it again.

The Carlsbad, Calif.-based company has purchased the assets of microarray maker Xeotron of Houston, Texas, for an undisclosed sum, the company confirmed today.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.